21 May 2009
Ann Transplant 2009; 14(1): 86-86 :: ID: 880516
Chronic HPV infection is thought to be the main causative factor in the development of cervical cancer. The predominant mode of transmission is a sexual intercourse. Factors increasing the risk of HPV infection include an early sexual initiation, large number of partners, unprotected intercourse. HPV infection prevention is now considered to be a mode of primary prophylaxis of cervical cancer A significant role in prevention and eradication of HPV infection is seen in prophylactic vaccination which fully prevents HPV type 16, 18 infections considered responsible for 70% cases of cervical cancer and HPV
type 6, 11 responsible for genital warts. Vaccination and the adherence to the rules of "safe sex" may drastically reduce the incidence of cervical cancer and the spread of infection, also among the personnel of surgical theatres who are exposed to infected body parts during the course of their work. Direct contact of nursing staff with patients, especially chronically immunosuppressed transplant recipients exposes those team members to an infection risk. Preventive vaccinations currently protect medical professionals from HBV infections by stimulating the production of protective antibody levels. It is postulated that anti-HPV vaccination should be included in the protective vaccination schedule of medical professionals at a special risk of exposure.
Keywords: Primary prophylaxis
12 Feb 2024 : Original articleNo Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...
Ann Transplant In Press; DOI: 10.12659/AOT.942767
Most Viewed Current Articles
05 Apr 2022 : Original articleImpact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original articleRisk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original articleLong-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...
Ann Transplant 2022; 27:e937988